Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immunoglobulin epsilon chain C region (membrane-bound form) is the constant region of the heavy chain specific to Immunoglobulin E (IgE), an antibody isotype produced by B lymphocytes. This membrane-bound form acts as a receptor on the surface of B cells during the recognition phase of humoral immunity. Upon antigen binding, it triggers clonal expansion and differentiation of B cells into plasma cells that secrete IgE antibodies. Secreted IgE mediates effector functions primarily through interaction with Fc receptors on myeloid and lymphoid cells: high-affinity receptor: FcεRI complex; low-affinity receptor: FCER2 (CD23). These interactions are central to allergic responses and defense against certain parasites.
Binds antigen, activates B cell signaling pathways, leading to plasma cell differentiation and IgE secretion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin Epsilon Chain C Region, Membrane-Bound Form (IgE).